01681nam0 22003733i 450 VAN009426020221216092849.47688-7959-144-420130715d1997 |0itac50 baitaIT|||| |||||Guida alla soluzione dei problemi da chimica organicaBrent L. Iverson e Sheila A. Iversoncon la collaborazione di William H. BrownNapoliEdiSES[1997]823 p.28 cmNapoliVANL000005547Chimica organica22IversonBrent L.VANV06662766509IversonSheila A.VANV06662866510BrownWilliam H.VANV012186EdiSES <editore>VANV108040650Iverson, B. L.Iverson, Brent L.VANV101070Iverson, B.L.Iverson, Brent L.VANV205950Iverson, S. A.Iverson, Sheila A.VANV101071Iverson, S.A.Iverson, Sheila A.VANV205951Brown, W. H.Brown, William H.VANV101072Brown, W.H.Brown, William H.VANV205952Brown, William HenryBrown, William H.VANV213574ITSOL20231222RICABIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHEIT-CE0101VAN17VAN0094260BIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE17CONS Fondo E. Fattorusso II 17BIB22 8 20140717 SottolineatoGuida alla soluzione dei problemi da Chimica organica377647UNICAMPANIA01613nam--2200433---450-99000303314020331620071212142432.0000303314USA01000303314(ALEPH)000303314USA0100030331420071212d1993----km-y0itay0103----bafreLU||||||||001yyEnseignements de troisième cycle sur l'intégration européenneCommission des Communautés européennesLuxembourgOffice des publications officielles des Communautés européennes1993142 p.21 cmSupplément aux "Nouvelles universitaires européennes"Istituti di istruzione superioreCooperazionePaesi della Comunità europeaUniversitàPaesi della Comunità europeaProgrammi378.10406.05Programmi scolasticiCommissione europea333284ITsalbcISBD990003033140203316CDE 06.05 (XIX)CDE 535CDE 06.0500148535BKCDEMARIAS9020071212USA011424MARIAS9020080221USA011130MARIAS9020080221USA011151MARIAS9020080221USA011322MARIAS9020080703USA011024MARIAS9020080703USA011027MARIAS9020080703USA011031BATCH-UPD9020111212USA011717Enseignements de troisième cycle sur l'intégration européenne1025802UNISA03963nam 2200709Ia 450 991110687980332120251006140348.097866124125619781282412569128241256697803091369140309136911(CKB)2420000000001441(EBL)3378544(SSID)ssj0000439079(PQKBManifestationID)11311299(PQKBTitleCode)TC0000439079(PQKBWorkID)10460128(PQKB)11441070(MiAaPQ)EBC3378544(Au-PeEL)EBL3378544(CaPaEBR)ebr10347048(CaONFJC)MIL241256(OCoLC)923280232(Perlego)4736026(BIP)27376687(EXLCZ)99242000000000144120090818d2009 uy 0engur|n|---|||||txtccrLive variola virus considerations for continuing research /Committee on the Assessment of Future Scientific Needs for Live Variola Virus; Board on Global Health ; Ann M. Arvin and Deepali M. Patel, editors ; Institute of Medicine of the National Academies1st ed.Washington, D.C. National Academies Press20091 online resource (170 p.)Description based upon print version of record.9780309136907 0309136903 Includes bibliographical references.""Reviewers""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 Overview of Smallpox and Its Surveillance and Control""; ""3 Comparative Poxvirology""; ""4 Animal Models Using Variola and Other Orthopoxviruses""; ""5 Genomic Analysis""; ""6 Development of Therapeutics""; ""7 Development of Vaccines""; ""8 Methods for Detection and Diagnosis""; ""9 Discovery Research""; ""10 Conclusions and Recommendations""; ""Appendix: Variola Strains Used to Validate Diagnostic and Detection Assays""Smallpox was a devastating disease that decimated human populations for centuries, and its eradication in 1980 was a monumental achievement for the global health community. Since then the remaining known strains of its causative agent, variola virus, have been contained in two World Health Organization (WHO)-approved repositories. In 1999, the World Health Assembly (WHA) debated the issue of destroying these remaining strains. Arguments were presented on the need to retain the live virus for use in additional important research, and the decision to destroy the virus was deferred until this research could be completed. In that same year, the Institute of Medicine (IOM) convened a consensus committee to explore scientific needs for the live virus. In the ten years since the first IOM report, the scientific, political, and regulatory environments have changed. In this new climate, the IOM was once again tasked to consider scientific needs for live variola virus. The committee evaluated the scientific need for live variola virus in four areas: development of therapeutics, development of vaccines, genomic analysis, and discovery research. SmallpoxResearchSmallpoxPreventionSmallpox vaccineVirologyCultures and culture mediaSmallpoxResearch.SmallpoxPrevention.Smallpox vaccine.VirologyCultures and culture media.616.912Arvin Ann M1945596Patel Deepali1642963Institute of Medicine (U.S.).Committee on the Assessment of Future Scientific Needs for Live Variola Virus.MiAaPQMiAaPQMiAaPQBOOK9911106879803321Live variola virus4700464UNINA